$3.110
-0.125 (-4.01%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ALT Prediction & Forecast by Similar Chart Analysis
Alphio's ALT stock price prediction model matches the current Altimmune Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.06 (-1.50%). The 1-week path is $3.11 (+0.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Altimmune Inc Stock?
Altimmune Inc is a good buy right now due to its promising trial results for pemvidutide, which met key endpoints, and a strong analyst price target of $20, indicating significant upside potential. The current price is $3.11, and the stock has shown a 9.51% increase over the last 20 days, reflecting positive momentum. However, the main risk is the company's ongoing net losses, with a net income of -$22,825,000 reported for Q2 2026, which could impact investor sentiment if not addressed.
ALT stock price ended at $3.11 on Friday, after losing -4.01%
Altimmune Inc (ALT) last closed at $3.11, losing -4.01%. These facts feed the 1-day and 1-week ALT price prediction above.
Analyst Consensus
Altimmune Inc (ALT): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Altimmune Inc (ALT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ALT, ranked by similarity.
Seasonality analysis for ALT
Historically the probability of a positive August return for ALT is 0.00%. January offers the highest probability of a positive month at 54.10%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.